X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (253) 253
male (228) 228
female (225) 225
adult (202) 202
psychiatry (193) 193
middle aged (170) 170
bipolar disorder (97) 97
schizophrenia (89) 89
neurosciences (79) 79
index medicus (77) 77
clinical neurology (69) 69
treatment outcome (62) 62
pharmacology & pharmacy (54) 54
genotype (53) 53
major depression (51) 51
psychiatric status rating scales (50) 50
depression (47) 47
bipolar disorder - genetics (43) 43
bipolar disorder - psychology (37) 37
aged (35) 35
schizophrenia - genetics (32) 32
polymorphism, genetic (30) 30
schizophrenic psychology (30) 30
alleles (29) 29
fluvoxamine (29) 29
serotonin (28) 28
sleep deprivation (28) 28
adolescent (27) 27
genetics & heredity (27) 27
mood disorders - genetics (27) 27
polymorphism, genetic - genetics (27) 27
bipolar disorder - diagnosis (26) 26
depressive disorder - psychology (26) 26
depressive disorder, major - drug therapy (26) 26
lithium (26) 26
association (25) 25
bipolar disorder - drug therapy (25) 25
polymorphism (25) 25
severity of illness index (25) 25
brain (24) 24
depressive disorder - drug therapy (24) 24
functional polymorphism (24) 24
analysis of variance (23) 23
genetics (23) 23
serotonin transporter gene (23) 23
antidepressive agents - therapeutic use (22) 22
follow-up studies (22) 22
mood disorders (22) 22
serotonin uptake inhibitors - therapeutic use (22) 22
bipolar disorder - therapy (21) 21
depressive disorder (21) 21
major depressive disorder (21) 21
age of onset (20) 20
double-blind method (20) 20
recurrence (20) 20
analysis (18) 18
bipolar affective-disorder (18) 18
depressive disorder - genetics (18) 18
antidepressants (17) 17
antipsychotic agents - therapeutic use (17) 17
depressive disorder, major - diagnosis (17) 17
disorder (17) 17
gene frequency (17) 17
genetic aspects (17) 17
magnetic resonance imaging (17) 17
neuropsychological tests (17) 17
paroxetine (17) 17
phenotype (17) 17
prefrontal cortex (17) 17
receptors, dopamine d2 - genetics (17) 17
risk factors (17) 17
catechol o-methyltransferase - genetics (16) 16
depression, mental (16) 16
depressive disorder, major - psychology (16) 16
efficacy (16) 16
fluvoxamine - therapeutic use (16) 16
membrane glycoproteins - genetics (16) 16
pharmacogenetics (16) 16
polymerase chain reaction (16) 16
serotonin plasma membrane transport proteins (16) 16
symptoms (16) 16
time factors (16) 16
antidepressant response (15) 15
case-control studies (15) 15
depressive disorder, major - genetics (15) 15
lithium - therapeutic use (15) 15
obsessive-compulsive disorder (15) 15
antidepressive agents, second-generation - therapeutic use (14) 14
combined modality therapy (14) 14
no association (14) 14
schizophrenia - drug therapy (14) 14
antidepressant (13) 13
bipolar depression (13) 13
carrier proteins - genetics (13) 13
delusions - psychology (13) 13
italy (13) 13
neuroimaging (13) 13
psychology, clinical (13) 13
serotonin plasma membrane transport proteins - genetics (13) 13
young adult (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Neurological Sciences, ISSN 1590-1874, 6/2014, Volume 35, Issue 6, pp. 855 - 859
Journal Article
The International Journal of Neuropsychopharmacology, ISSN 1461-1457, 3/2002, Volume 5, Issue 1, pp. 27 - 35
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 07/2009, Volume 15, Issue 22, pp. 2637 - 2649
Despite confirmed evidences about some neurochemical effects of antidepressant treatments, there is still a high level of uncertainty about which biological... 
Journal Article
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2001, Volume 50, Issue 5, pp. 323 - 330
Background: It has been recently reported that the short variant of the serotonin transporter (5-HTT) gene-linked functional polymorphic region (5-HTTLPR)... 
Serotonin transporter | fluvoxamine | depression | pindolol | treatment response | pharmacogenetics | Depression | Pharmacogenetics | Treatment response | Fluvoxamine | Pindolol | FUNCTIONAL POLYMORPHISM | PSYCHIATRY | BIPOLAR AFFECTIVE-DISORDER | MAJOR DEPRESSION | SEROTONIN TRANSPORTER GENE | RESPONSIVE AFFECTIVE-DISORDERS | NONPSYCHOTIC DEPRESSION | NEUROSCIENCES | serotonin transporter | PSYCHOTIC DEPRESSION | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | COLLABORATIVE RESEARCH-PROGRAM | Humans | Middle Aged | Male | Serotonin Plasma Membrane Transport Proteins | Bipolar Disorder - diagnosis | Genetic Variation | Fluvoxamine - administration & dosage | Delusions - drug therapy | Pindolol - administration & dosage | Adult | Female | Delusions - genetics | Drug Therapy, Combination | Pindolol - adverse effects | Depressive Disorder, Major - drug therapy | Double-Blind Method | Serotonin Uptake Inhibitors - adverse effects | Genotype | Treatment Outcome | Nerve Tissue Proteins | Bipolar Disorder - drug therapy | Bipolar Disorder - genetics | Fluvoxamine - adverse effects | Membrane Glycoproteins - genetics | Carrier Proteins - genetics | Serotonin Uptake Inhibitors - administration & dosage | Depressive Disorder, Major - genetics | Membrane Transport Proteins | Delusions - diagnosis | Antidepressive Agents - administration & dosage | Polymorphism, Genetic - genetics | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis
Journal Article